Daewoong Pharmaceutical’s ‘Ursa’ Shows Symptom Improvement in Early Post-COVID Patients
Daewoong Pharmaceutical announced on the 9th that Ursodeoxycholic Acid , the primary ingredient in its flagship product Ursa, has shown signs of...
Search results for "drug treatment"
Korean Biotech Firms Join Forces to Uncover the Hidden Profiles of Cancer Cells
Even within a single tumor, cancer cells present many different "faces." While they may appear as a uniform mass, every individual cell possesses a...
Scentless Tea and Ineffective Medicine: The Hidden Conditions of "Essence"
“I thought there was a separate species of jasmine tea tree!” This is a common reaction when people learn that jasmine...
The Unexpected Heart Benefits of Weight Loss Injections: Reducing Complications After Heart Attack
New research indicates that the class of drugs used in popular weight loss injections may do more than shed pounds;...
Decoding the Blueprint of Aging: Scientists Map 7 Million Cells Across 21 Organs
We often attribute the appearance of wrinkles, declining stamina, and increased disease risk simply to "getting older.
When Life Mimics Art: Why a Cancer Diagnosis Can Trigger a ‘Breaking Bad’ Effect
In the critically acclaimed series Breaking Bad, a mild-mannered chemistry teacher responds to a terminal cancer...
Beyond the X-Ray: South Korean Researchers Develop AI to Pinpoint Precise Knee Osteoarthritis Wear
A South Korean research team has developed a breakthrough imaging indicator that utilizes AI deep learning to identify...
Rznomics to Present Oral Report on Breakthrough Anti-Cancer Gene Therapy at AACR
Rznomics, a biotechnology company specializing in RNA-based gene therapies, announced on March 5 that it has been...
2NE1’s Park Bom Addresses ‘ADD’ Diagnosis in Public Letter to Fans
Park Bom of the group 2NE1 stirred controversy by posting a lengthy letter on the 3rd.
Alteogen Poised for Surge in Milestone Revenue as Keytruda Qlex and Biosimilars Gain Momentum
Alteogen is set to accelerate its financial growth this year, driven by a surge in milestone payments and royalty...